Allan Camaisa
CEO, President and Chairman at Calidi Biotherapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Calidi Biotherapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Calidi Biotherapeutics Inc. August 28, 2023100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 12, 2025 | Calidi Biotherapeutics Inc. | Open-market sale | −850 | $1.46 | $1,241 |
| Dec 17, 2024 | Calidi Biotherapeutics Inc. | Open-market sale | −10,000 | $1.62 | $16,200 |
| Sep 26, 2024 | Calidi Biotherapeutics Inc. | Grant or award | +70,155 | $1.15 | $80,678 |
Questions about Allan Camaisa
What boards is Allan Camaisa on?
Allan Camaisa sits on the board of Calidi Biotherapeutics Inc.
Has Allan Camaisa been a CEO?
Yes — Allan Camaisa was CEO of Calidi Biotherapeutics Inc. (2023 – 2025).
How long has Allan Camaisa served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.